Wealth Enhancement Advisory Services, LLC Galectin Therapeutics Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $44.5 Billion
- Q3 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 35,098 shares of GALT stock, worth $95,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,098
Previous 34,910
0.54%
Holding current value
$95,466
Previous $78,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding GALT
# of Institutions
90Shares Held
9.57MCall Options Held
1.16MPut Options Held
1.98M-
Vanguard Group Inc Valley Forge, PA2.13MShares$5.81 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$4.25 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$3.22 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA863KShares$2.35 Million0.0% of portfolio
-
Commonwealth Equity Services, LLC483KShares$1.31 Million0.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $162M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...